Aliskiren
Back to searchMolecule Structure
Scientific Name
Aliskiren
Description of the Drug
Aliskiren is a direct renin inhibitor used to manage hypertension.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09026
http://www.drugbank.ca/drugs/DB09026
Brand Name(s)
Rasilez
Company Owner(s)
Anchen Pharmaceuticals Inc, Novartis Pharmaceuticals Corp, Noden Pharma Dac
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Renin | SINGLE PROTEIN | INHIBITOR | CHEMBL286 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL455490 | ||
| PharmGKB | PA143487910 | ||
| Human Metabolome Database | HMDB0015387 | ||
| DrugBank | DB09026 | ||
| PubChem: Thomson Pharma | 14886049 | 14763777 | |
| PubChem | 5493444 | ||
| Mcule | MCULE-6209020635 | ||
| LINCS | LSM-2653 | ||
| Nikkaji | J1.947.312K | ||
| PDBe | C41 | ||
| BindingDB | 17950 | ||
| EPA CompTox Dashboard | DTXSID40891494 | ||
| DrugCentral | 119 | ||
| Brenda | 54356 | 1609 | |
| ChemicalBook | CB9966226 | ||
| Guide to Pharmacology | 4812 | ||
| rxnorm | TEKTURNA | ALISKIREN HEMIFUMARATE | ALISKIREN |
| ChEBI | 601027 | ||
| ZINC | ZINC000004393164 |
